Related Experiment Video
Updated: Jun 30, 2026

Modeling Spontaneous Metastatic Renal Cell Carcinoma (mRCC) in Mice Following Nephrectomy
Published on: April 29, 2014
Renal cell carcinoma
1Comprehensive Cancer Center of Wake Forest University, Bowman Gray School of Medicine, Winston-Salem, NC 27157, USA.
Abstract:
Renal cell carcinoma remains a devastating disease known for insidious onset, with patients often having advanced incurable disease at the time of diagnosis. Biologic therapy with IL-2 offers a chance for prolonged remission for a minority of patients, but its toxicities preclude most patients from ever receiving it. Preclinical experiments and early results of novel clinical trials based on the latest theories in molecular oncology and immunology are leading to promising new treatments for this disease.
Insights
Renal cell carcinoma is a difficult cancer often diagnosed late. While interleukin-2 (IL-2) therapy helps some, its side effects limit use. New molecular and immunology-based treatments show promise for patients with kidney cancer.
Area of Science:
- Oncology
- Immunology
- Molecular Biology
Background:
- Renal cell carcinoma (RCC) presents insidiously, frequently diagnosed at advanced, incurable stages.
- Current biologic therapies like interleukin-2 (IL-2) offer limited remission chances due to significant toxicities, restricting patient eligibility.
Purpose of the Study:
- To explore novel therapeutic strategies for renal cell carcinoma.
- To investigate the potential of new treatments informed by advances in molecular oncology and immunology.
Main Methods:
- Review of preclinical experiments.
- Analysis of early-phase clinical trial results.
- Integration of current theories in molecular oncology and immunology.
Main Results:
- Identification of promising avenues for novel therapeutic development in RCC.
- Early data suggests potential for improved treatment outcomes in kidney cancer.
Conclusions:
- Despite challenges with existing treatments like IL-2, emerging research offers hope for more effective renal cell carcinoma therapies.
- Future directions in molecular and immunological approaches are critical for advancing kidney cancer treatment.
More Related Videos
06:38A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
Published on: April 12, 2017
05:36Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane
Published on: February 8, 2020
Related Concept Videos
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous capillaries...
Urinary Tract Calculi I: Introduction
Chronic Kidney Disease I: Introduction
Diabetic Nephropathy